Skip to main content

This job has expired

Postdoctoral Fellow - Cancer Immunotherapy

Employer
City of Hope
Location
Duarte, California
Salary
Competitive
Closing date
May 21, 2019

View more

Discipline
Life Sciences, Cancer Research
Position Type
Full Time
Organization Type
Healthcare/Hospital

Job Details

About City of Hope

City of Hope, an innovative biomedical research, treatment and educational institution with over 6,000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.

Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation's leading cancer centers that develops and institutes standards of care for cancer treatment.

Position Summary

The Postdoctoral Fellow position is available immediately in the Department of Immuno-Oncology at Beckman Research Institute in City of Hope Comprehensive Cancer Center, to explore mechanism of immune evasion in hematologic malignancies and to develop novel immunotherapeutic strategies. We seek applications from candidates with expertise in cancer immunotherapy and/or tumor immunology, with strong interests in translational research in animal models of human malignancies as well as in clinical studies. The environment of Beckman Research Institute is highly collaborative and these projects will involve multiple collaboration within the Brain Tumor Program at City of Hope and core laboratories across our Institution. Highly motivated individuals with strong communication skills and ability to work in high paced, multidisciplinary environment are invited to apply.

Key Responsibilities include:
  • The ideal candidate will be able to work independently on molecular and cellular mechanisms of immunosuppression in humanized and syngeneic mouse tumor models utilizing the original oligonucleotide-based approaches for targeting tolerogenic signaling.
  • They can also participate in the ongoing clinical translation of the immunogenic CpG-STAT3 inhibitors to cancer immunotherapy.
  • They will be responsible for drafting manuscripts, progress reports and presenting the results internally as well as extramurally when needed.

Basic education, experience and skills required for consideration:
  • A Ph.D. degree in life or biomedical sciences, or a related discipline is required.

Preferred education experience and skills:
  • Skills in multicolor flow cytometry and/or animal studies.

Additional Information:

For more information about the laboratory and institution, please see our publications (e.g. Nature Med. 2018, Mol. Ther. 2018, Blood 2016; Clin. Cancer Res. 2015; Blood 2014; Nature Biotechnol. 2009) and the following links:

https://www.cityofhope.org/people/kortylewski-marcin

https://www.cityofhope.org/research/beckman-research-institute

City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.

Company

City of Hope, an innovative biomedical research, treatment and educational institution with over 5,000 employees, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate, patient-centered philosophy.

Founded in 1913 and headquartered in Duarte, California, City of Hope is a remarkable non-profit institution, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research.  City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment.

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert